Atrium Therapeutics, Inc. · NASDAQ:RNA
Atrium Therapeutics, Inc. shareholders
As of Sep 30, 2026, 144 institutions reported holding Atrium Therapeutics, Inc., 82.1% of its shares. Largest: Sessa Capital IM, L.P., BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Atrium Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Sessa Capital IM, L.P. | 1.5M | 8.8% | no change | Nov 16, 2026 |
| BlackRock | 1.22M | 7.1% | −229K | Nov 13, 2026 |
| Vanguard | 949K | 5.5% | +1,232 | Nov 13, 2026 |
| T. Rowe Price | 640K | 3.7% | −833K | Nov 16, 2026 |
| O'Connor Alternative Investments, LLC | 559K | 3.3% | new | Nov 16, 2026 |
| Bracebridge Capital, LLC | 524K | 3.1% | +385K | Nov 16, 2026 |
| TIG Advisors, LLC | 507K | 3.0% | −54,607 | Nov 16, 2026 |
| Bank of America | 468K | 2.7% | +335K | Nov 16, 2026 |
| Two Sigma | 427K | 2.5% | +81,903 | Nov 16, 2026 |
| Geode Capital | 380K | 2.2% | −7,113 | Nov 6, 2026 |